MedTrace Logo

Ceramic on Metal Total Hip Replacement System Multi-Center,Investigational Device Exemption Clinical Trial

NCT00820443 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2015-09-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate non-inferiority of the Ceramic on Metal Total Hip when compared to a TRANSCEND® historical control group of patients with primary total hip replacement.

Conditions

  • Total Hip Replacement System

Interventions

DEVICE

Ceramic on metal prosthesis

Ceramic femoral head with a metal acetabular component

Sponsors & Collaborators

  • MicroPort Orthopedics Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2013-06-30
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00820443 on ClinicalTrials.gov